Serina Therapeutics (Serina Therapeutics) Long-Term Capital Lease Obligation : $0.41 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Long-Term Capital Lease Obligation?

Serina Therapeutics's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.41 Mil.

Serina Therapeutics's quarterly Long-Term Capital Lease Obligation increased from Dec. 2022 ($0.06 Mil) to Jun. 2023 ($0.39 Mil) and increased from Jun. 2023 ($0.39 Mil) to Mar. 2024 ($0.41 Mil).

Serina Therapeutics's annual Long-Term Capital Lease Obligation increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.19 Mil) but then declined from Dec. 2021 ($0.19 Mil) to Dec. 2022 ($0.06 Mil).

Serina Therapeutics Long-Term Capital Lease Obligation Historical Data

The historical data trend for Serina Therapeutics's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Long-Term Capital Lease Obligation Chart

Serina Therapeutics Annual Data

Trend

Dec21

Dec22

Long-Term Capital Lease Obligation

0.19

0.06

Serina Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Mar24
Long-Term Capital Lease Obligation	0.19	-	0.06	0.39	0.41

Serina Therapeutics (AMEX:SER) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Serina Therapeutics Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics (Serina Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

2BO:Germany

Address

601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806

Website

https://www.serinatherapeutics.com

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines

From GuruFocus

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse� for Advanced Parkinson's Disease

By Marketwired • 05-15-2024